Moneycontrol
SENSEX NIFTY
you are here:

Aurobindo Pharma Ltd.

BSE: 524804 | NSE: AUROPHARMA |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE406A01037 | SECTOR: Pharmaceuticals

BSE Live

Jul 13, 11:42
812.65 -8.10 (-0.99%)
Volume
AVERAGE VOLUME
5-Day
176,046
10-Day
137,204
30-Day
161,373
185,117
  • Prev. Close

    820.75

  • Open Price

    825.00

  • Bid Price (Qty.)

    812.50 (195)

  • Offer Price (Qty.)

    812.80 (74)

NSE Live

Jul 13, 11:42
812.75 -8.00 (-0.97%)
Volume
AVERAGE VOLUME
5-Day
3,920,261
10-Day
3,511,655
30-Day
4,795,661
1,479,236
  • Prev. Close

    820.75

  • Open Price

    827.10

  • Bid Price (Qty.)

    812.75 (113)

  • Offer Price (Qty.)

    812.85 (42)

Financials

2019 2018 2017 2016 2015
Quarterly Results of Aurobindo Pharma (in Rs. Cr.) Mar '20 Dec '19 Sep '19 Jun '19 Mar '19  
Net Sales/Income from operations 3,534.28 3,258.10 3,145.12 2,997.03 3,196.20  
Other Operating Income 86.04 87.57 76.54 81.80 84.38  
Total Income From Operations 3,620.32 3,345.67 3,221.66 3,078.83 3,280.58  
EXPENDITURE  
Consumption of Raw Materials 1,792.76 1,753.23 1,586.16 1,615.40 1,708.20  
Purchase of Traded Goods 0.68 1.11 1.34 2.38 0.58  
Increase/Decrease in Stocks -126.92 -64.90 38.01 -75.72 -136.90  
Power & Fuel -- -- -- -- --  
Employees Cost 424.94 384.91 374.06 377.56 361.82  
depreciat 118.85 118.55 117.93 115.15 109.33  
Excise Duty -- -- -- -- --  
Admin. And Selling Expenses -- -- -- -- --  
R & D Expenses -- -- -- -- --  
Provisions And Contingencies -- -- -- -- --  
Exp. Capitalised -- -- -- -- --  
Other Expenses 680.27 620.14 590.88 608.80 612.54  
P/L Before Other Inc. , Int., Excpt. Items & Tax 729.74 532.63 513.28 435.26 625.01  
Other Income 160.61 37.98 33.64 30.14 28.31  
P/L Before Int., Excpt. Items & Tax 890.35 570.61 546.92 465.40 653.32  
Interest 17.46 21.31 24.86 31.95 34.84  
P/L Before Exceptional Items & Tax 872.89 549.30 522.06 433.45 618.48  
Exceptional Items -- -- -- -- --  
P/L Before Tax 872.89 549.30 522.06 433.45 618.48  
Tax 147.85 130.23 123.93 102.95 158.34  
P/L After Tax from Ordinary Activities 725.04 419.07 398.13 330.50 460.14  
Prior Year Adjustments -- -- -- -- --  
Extra Ordinary Items -- -- -- -- --  
Net Profit/(Loss) For the Period 725.04 419.07 398.13 330.50 460.14  
Equity Share Capital 58.59 58.59 58.59 58.59 58.59  
Reserves Excluding Revaluation Reserves -- -- -- -- --  
Equity Dividend Rate (%) -- -- -- -- --  
EPS Before Extra Ordinary  
Basic EPS 12.37 7.15 6.80 5.64 7.85  
Diluted EPS 12.37 7.15 6.80 5.64 7.85  
EPS After Extra Ordinary  
Basic EPS. 12.37 7.15 6.80 5.64 7.85  
Diluted EPS. 12.37 7.15 6.80 5.64 7.85  
Public Share Holding  
No Of Shares (Crores) -- -- -- -- --  
Share Holding (%) -- -- -- -- --  
Promoters and Promoter Group Shareholding  
a) Pledged/Encumbered  
- Number of shares (Crores) -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --  
b) Non-encumbered  
- Number of shares (Crores). -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group). -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company). -- -- -- -- --  
Source : Dion Global Solutions Limited